Zydus Lifesciences has informed that the Board of Directors at their meeting held today, May 19, 2026, has approved: 1. holding of Thirty First Annual General Meeting (‘AGM’) of the members of the Company on Tuesday, August 11, 2026, through Video Conference / Other Audio Visual Means, 2. final dividend of Re 1 (@ 100%) per equity share of Re 1 each, subject to approval of the shareholders at the AGM and 3. the Record Date as Friday, July 24, 2026, in compliance with regulation 42(1) of the Listing Regulations, to determine the list of shareholders entitled to receive the final dividend for the Financial Year ended on March 31, 2026, payment of which shall be subject to the approval by the members at the AGM. The Company shall make the payment of dividend, subject to deduction of tax at source, on or around Friday, August 14, 2026, subject to the approval of the same by the shareholders at the AGM.
